Andere talen Lincoln Pharmaceuticals Limited NSE India S.E.

Aandelen

LINCOLN

INE405C01035

Beurs gesloten - NSE India S.E. Andere beurzen 13:40:30 21-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
568,6 ^INR	-1,57%		+0,01%	-6,71%

16/05	Lincoln Pharmaceuticals Limited rapporteert resultaten voor het vierde kwartaal eindigend op 31 maart 2024	CI
16/05	Lincoln Pharmaceuticals Limited rapporteert resultaten voor het volledige jaar dat eindigde op 31 maart 2024	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Lincoln Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	16/05
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024	16/05
Lincoln Pharmaceuticals Limited Recommends Dividend for the Year Ended March 31, 2024	16/05
Lincoln Pharmaceuticals Limited Announces Pirabhai Suthar Will Cease to Be an Independent Director	30/03
Lincoln Pharmaceuticals Limited Announces Resignation of Meha Patel as Non-Executive Independent women Director	22/02
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	08/02
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	02/11
Lincoln Pharmaceuticals Limited Declares Dividend for the Financial Year 2022-23	30-09-23
Lincoln Pharmaceuticals Limited Proposes Dividend for the Financial Year 2022-2023	06-09-23
Lincoln Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	10-08-23
Lincoln Pharmaceuticals Limited Recommends A Dividend for the Year Ended March 31, 2023	25-05-23
Lincoln Pharmaceuticals Limited Approves the Resignation of Anand A. Patel from the Position of Whole Time Director as Well as Director of the Company	25-05-23
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	25-05-23
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	09-02-23
Lincoln Pharmaceuticals Limited Informs About Demise of Shri Ishwarlal Ambalal Patel Independent Director	05-12-22
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	10-11-22
Lincoln Pharmaceuticals Limited Appoints Trusha Shah as Company Secretary and Compliance Officer	10-11-22
Lincoln Pharmaceuticals Limited Approves to Declare Dividend for the Financial Year 2021-22	30-09-22
Lincoln Pharmaceuticals Limited Proposes to Declare Dividend for the Financial Year 2021-2022	06-09-22
Lincoln Pharmaceuticals Limited Approves Appointment of Anand A. Patel as an Additional and Whole Time Director	09-08-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Lincoln Pharmaceuticals Limited NSE India S.E.

Aandelen

LINCOLN

INE405C01035

Andere talen

Filters